A Systematic Review Connecting Pregnancy-Induced Hypertension to Neonatal Outcomes
Authors/Creators
- 1. International Journal of Medical Science and Innovative Research (IJMSIR)
Description
Abstract
Using data from 20 studies published between 2000–2025, this systematic review examines the relationship between pregnancy-induced hypertension (PIH) and neonatal outcomes. 5–10% of pregnancies are affected by PIH, which is defined by elevated blood pressure after 20 weeks of gestation and is associated with a range of newborn outcomes. Although some research indicates that preterm newborns with PIH have lower mortality and fewer morbidities, severe PIH and preeclampsia are linked to higher chances of stillbirth, low birth weight, necrotizing enterocolitis, and bronchopulmonary dysplasia. The review emphasizes how crucial it is to differentiate between gestational age and the severity of PIH when evaluating newborn hazards. Mitigating negative consequences requires effective management, which includes hypertension medication and preventative measures like low-dose aspirin.
Furthermore, unequal prenatal care is necessary since healthcare inequities have a substantial impact on newborn health. To further understand and address the impact of PIH, future research should concentrate on standardized assessments and long-term neonatal outcomes.
Files
SOUMYA.pdf
Additional details
Software
References
- 1. American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237–e260. 2. World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: WHO; 2011. 3. Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43. 4. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. 5. Davis EF, Lazdam M, Lewandowski AJ, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–e1561. 6. Razak A, Florendo-Chin A, Banfield L, et al. Pregnancy-induced hypertension and neonatal outcomes: a systematic review and meta-analysis. J Perinatol. 2018;38(1):46–53. 7. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143–8. 8. Usta IM, Nassar AH. Advanced maternal age. Part I: obstetric complications. Am J Perinatol. 2008;25(8):521–34. 9. Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy-induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovasc Disord. 2015;15:111. 10. Gibson KS, Waters TP, Bailit JL. A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies. Am J Obstet Gynecol. 2016;214(3):389.e1–389.e12. 11. American Heart Association. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2021;78(6):e1–e21. 12. National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. 2019. 13. Tita AT, Szychowski JM, Boggess K, CHAP Trial Consortium. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386:1781–92. 14. Howell EA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol. 2018;61(2):387–99. 15. Hauspurg A, Venkatakrishnan K, Collins L, et al. Postpartum ambulatory blood pressure patterns following new-onset hypertensive disorders of pregnancy. JAMA Cardiol. 2024;9(6):e1–e10.